Some of the most encouraging clinical results have been reported for a DCV consisting of autologous dendritic cells (DC) that were loaded with autologous tumor antigens (ATA) from autologous tumor cells that were self-renewing in tissue culture, and administered in granulocyte-macrophage colony stimulating factor (GM-CSF) [14,15,16,17,18]. Here, CSF2 is linked to neoplasm.